March 06, 2020 — The U.S. Food and Drug Administration today approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the…Original Article
FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease
